Flomoxef

From Self-sufficiency
Revision as of 07:34, 8 September 2010 by Arcadian (Talk) (ref)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Flomoxef
File:Flomoxef.png
Systematic (IUPAC) name
(6R,7R)-7-[[2-(Difluoromethylsulfanyl)acetyl]amino]-3- [[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]- 7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Identifiers
CAS Number 99665-00-6
ATC code none
PubChem CID 65864
Chemical data
Formula C15H18F2N6O7S2
Molar mass 496.46 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Flomoxef (INN) is an oxacephem antibiotic.

It has been identified as second-generation [1] and fourth generation.[2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
50px This systemic antibacterial-related article is a stub. You can help ssf by expanding it.
Intracellular
inhibit peptidoglycan subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin) · DADAL/AR inhibitors (Cycloserine) · bactoprenol inhibitors (Bacitracin)
Glycopeptide
inhibit PG chain elongation: Vancomycin# (Oritavancin, Telavancin) · Teicoplanin (Dalbavancin) · Ramoplanin
β-lactams/
(inhibit PBP
cross-links)
Combinations
Other

M: BAC

drug(J1p, w, n, m, vacc)

  1. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  2. ↑ Ito M, Ishigami T (1991). "The meaning of the development of flomoxef and clinical experience in Japan". Infection. 19 Suppl 5: S253–7. PMID 1783441. 
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Flomoxef&oldid=23441"